Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 2/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.44 |
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | NR3C2 | P08235 | 4/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.40 |
| ▸ | PGR | P06401 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | IL4I1 | Q96RQ9 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4100769 | 0.84 | MMP12 (0.44) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL4290482 | 0.81 | IL4I1 (0.44) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL21552045 | 0.79 | PGR (0.42) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL20278370 | 0.78 | PDE3B (0.55) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL4480236 | 0.76 | PDE3B (0.41) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL4288420 | 0.76 | PDE3B (0.47) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL17875671 | 0.76 | PDE3B (0.43) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL8082246 | 0.73 | PGR (0.46) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL4102430 | 0.72 | PARP1 (0.44) | PDE3BPDE3AMMP12NR3C2NR3C1 | |
| SCHEMBL8236302 | 0.71 | IL4I1 (0.44) | PDE3BPDE3AMMP12NR3C2NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |